Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jun;12(3):e1195.
doi: 10.1002/prp2.1195.

Impact of pharmaceutical care for asthma patients on health-related outcomes: An umbrella review

Olalla Montero Pérez  1 , Fernando Salazar González  2 , Ernesto Sánchez Gómez  3 , Concepción Pérez Guerrero  4
Affiliations

Impact of pharmaceutical care for asthma patients on health-related outcomes: An umbrella review

Olalla Montero Pérez et al. Pharmacol Res Perspect. 2024 Jun.

Abstract

Recent systematic reviews suggest that pharmacists' interventions in asthma patients have a positive impact on health-related outcomes. Nevertheless, the association is not well established, and the role of clinical pharmacists is poorly represented. The aim of this overview of systematic reviews is to identify published systematic reviews assessing the impact of pharmacists' interventions on health-related outcomes measured in asthma patients. PubMed, Embase, Scopus, and Cochrane Library were searched from inception to December 2022. Systematic reviews of all study designs and settings were included. Methodological quality was assessed using AMSTAR 2. Two investigators performed study selection, quality assessment and data collection independently. Nine systematic reviews met the inclusion criteria. Methodological quality was rated as high in one, low in two, and critically low in six. Reviews included 51 primary studies reporting mainly quality of life, asthma control, lung capacity, and therapeutic adherence. Only four studies were carried out in a hospital setting and only two reviews stated the inclusion of severe asthma patients. The quality of the systematic reviews was generally low, and this was the major limitation of this overview of systematic reviews. However, solid evidence supports that pharmaceutical care improves health-related outcomes in asthma patients.

Keywords: asthma; clinical pharmacist; outcome assessment, health care; pharmaceutical care; systematic review.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

FIGURE 1
FIGURE 1
Preferred reporting items for systematic reviews and meta‐analyses literature search and study selection flowchart.
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Sociedad Española de Neumologia y Cirugía Torácica . GEMA 5.3. Guía Española para el Manejo del Asma . Accessed August 30, 2023. https://www.gemasma.com/ 2023.
    1. Côté A, Godbout K, Boulet LP. The management of severe asthma in 2020. Biochem Pharmacol. 2020;179:114112. doi:10.1016/j.bcp.2020.114112 - DOI - PubMed
    1. Rolland‐Debord C, Goriounov I, Pitron V. Le fardeau psychologique de l'asthme. Rev Mal Respir. 2021;38(7):721‐732. doi:10.1016/j.rmr.2021.01.018 - DOI - PubMed
    1. Dafauce L, Romero D, Carpio C, et al. Psycho‐demographic profile in severe asthma and effect of emotional mood disorders and hyperventilation syndrome on quality of life. BMC Psychol. 2021;9(1):3. doi:10.1186/s40359-020-00498-y - DOI - PMC - PubMed
    1. Voll‐Aanerud M, Eagan TML, Plana E, et al. Respiratory symptoms in adults are related to impaired quality of life, regardless of asthma and COPD: results from the European community respiratory health survey. Health Qual Life Outcomes. 2010;8:107. doi:10.1186/1477-7525-8-107 - DOI - PMC - PubMed

Publication types

Substances